skb518
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jun 30, 2024 (NCT06428331)
Timeline
Indications
Studied for
Mechanism of action
- Inactive tyrosine-protein kinase 7INHIBITOR
PTK7 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07019675 | Phase 2 | Jun 20, 2025 | Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
| NCT06428331 | Phase 1 | Jun 30, 2024 | Fudan University, Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sichuan Kelun Pharmaceutical Research Institute Co., Ltd. | For profit | 2 | 2 | 2 | 2024 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1